Vaxcell Bio Valuation
| 323990 Stock | KRW 12,810 390.00 2.95% |
At this time, the company appears to be overvalued. Vaxcell Bio Therapeu has a current Real Value of W10934.7 per share. The regular price of the company is W12810.0. Our model measures the value of Vaxcell Bio Therapeu from inspecting the company fundamentals such as Shares Owned By Institutions of 3.92 %, return on equity of -21.18, and EBITDA of (4.06 B) as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Vaxcell Bio's price fluctuation is very steady at this time. Calculation of the real value of Vaxcell Bio Therapeu is based on 3 months time horizon. Increasing Vaxcell Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vaxcell Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vaxcell Stock. However, Vaxcell Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12810.0 | Real 10934.7 | Hype 12810.0 | Naive 13455.8 |
The real value of Vaxcell Stock, also known as its intrinsic value, is the underlying worth of Vaxcell Bio Therapeu Company, which is reflected in its stock price. It is based on Vaxcell Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vaxcell Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vaxcell Bio Therapeutics Co helps investors to forecast how Vaxcell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vaxcell Bio more accurately as focusing exclusively on Vaxcell Bio's fundamentals will not take into account other important factors: Vaxcell Bio Total Value Analysis
Vaxcell Bio Therapeutics Co is presently forecasted to have takeover price of 1.06 T with market capitalization of 554.12 B, debt of 37.39 M, and cash on hands of 27.31 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vaxcell Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.06 T | 554.12 B | 37.39 M | 27.31 B |
Vaxcell Bio Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Vaxcell suggests not a very effective usage of assets in November.Vaxcell Bio Ownership Allocation
The market capitalization of Vaxcell Bio is W554.12 Billion. Vaxcell Bio Therapeu has 13.55 % of its outstanding shares held by insiders and 3.92 % owned by institutional holders. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Vaxcell Bio Profitability Analysis
Net Loss for the year was (4.76 B) with loss before overhead, payroll, taxes, and interest of (5.39 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vaxcell Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vaxcell Bio and how it compares across the competition.
About Vaxcell Bio Valuation
The stock valuation mechanism determines Vaxcell Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vaxcell Bio. We calculate exposure to Vaxcell Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vaxcell Bio's related companies.Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. Vaxcell Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Vaxcell Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vaxcell Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vaxcell Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vaxcell Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vaxcell Bio's revenue streams: Identify Vaxcell Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vaxcell Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vaxcell Bio's growth potential: Evaluate Vaxcell Bio's management, business model, and growth potential.
- Determine Vaxcell Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vaxcell Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Vaxcell Stock analysis
When running Vaxcell Bio's price analysis, check to measure Vaxcell Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcell Bio is operating at the current time. Most of Vaxcell Bio's value examination focuses on studying past and present price action to predict the probability of Vaxcell Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcell Bio's price. Additionally, you may evaluate how the addition of Vaxcell Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance |